Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03650894 |
|---|---|
| Brief Title: | Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients |
| First Submitted : | August 27, 2018 |
| First Submitted that Met QC Criteria : | August 28, 2018 |
| First Posted : | August 29, 2018 |
| Last Update Submitted that Met QC Criteria : | December 21, 2022 |
| Last Update Posted : | December 23, 2022 |